World's Best Scientists 2026 revealed!

D-Index & Metrics

Discipline name D-Index World Ranking Current World Ranking National Ranking Current National Ranking Publications Citations
Medicine 100 8184 7695 4244 3931 523 44325

Ann H. Partridge publications per year

The chart shows the history of publications by Ann H. Partridge between 2000 and 2025, highlighting the no. of papers published in each year and offering an overview of the publication velocity of this scholar. Ann H. Partridge published across 26 years, from 2000 to 2025, averaging 39.1 papers a year. Output peaked at 202 publications in 2023. 225 of the 1,016 publications appeared in the last two years.

No. of publications
50 100 150 200
Bar chart. Horizontal axis: year, 2000 to 2025. Vertical axis: number of publications, 0 to 202. Peak 202 publications in 2023. 2000: 5 publications 2001: 3 publications 2002: 7 publications 2003: 5 publications 2004: 5 publications 2005: 10 publications 2006: 10 publications 2007: 8 publications 2008: 13 publications 2009: 15 publications 2010: 11 publications 2011: 18 publications 2012: 32 publications 2013: 39 publications 2014: 27 publications 2015: 42 publications 2016: 25 publications 2017: 44 publications 2018: 36 publications 2019: 52 publications 2020: 49 publications 2021: 67 publications 2022: 66 publications 2023: 202 publications 2024: 133 publications 2025: 92 publications
2000 2025

1,016 publications in total across all disciplines

View publications per year as a table
Ann H. Partridge: publications per year, 2000 to 2025
Year Publications
2000 5
2001 3
2002 7
2003 5
2004 5
2005 10
2006 10
2007 8
2008 13
2009 15
2010 11
2011 18
2012 32
2013 39
2014 27
2015 42
2016 25
2017 44
2018 36
2019 52
2020 49
2021 67
2022 66
2023 202
2024 133
2025 92
Total 1,016
Download as CSV

Ann H. Partridge publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Ann H. Partridge sits on this spectrum.

No. of scientists
200 400 600 800
Bar chart with 86 bars. Horizontal axis: publications, 101–120 to 1,796+. Vertical axis: number of scientists, 0 to 922. Most scientists, 922, have 341–360 publications. The last bar groups every scientist with 1,796 publications or more. The highlighted bar, 521–540 publications, is where this scientist sits. 101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101–120 publications 1,796+

This scientist: 523 publications — 62nd percentile

62% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

View publications distribution as a table
Number of Medicine scientists by publication count, Research.com 2026 ranking edition. Based on 20,134 ranked scientists.
Publications Scientists This scientist
101–120 5
121–140 26
141–160 73
161–180 155
181–200 230
201–220 363
221–240 487
241–260 545
261–280 722
281–300 768
301–320 834
321–340 895
341–360 922
361–380 838
381–400 861
401–420 918
421–440 806
441–460 771
461–480 751
481–500 713
501–520 617
521–540 610 523
541–560 537
561–580 504
581–600 509
601–620 396
621–640 386
641–660 371
661–680 340
681–700 336
701–720 307
721–740 259
741–760 230
761–780 228
781–800 217
801–820 204
821–840 186
841–860 177
861–880 155
881–900 139
901–920 145
921–940 116
941–960 133
961–980 91
981–1,000 96
1,001–1,020 77
1,021–1,040 70
1,041–1,060 63
1,061–1,080 77
1,081–1,100 49
1,101–1,120 54
1,121–1,140 49
1,141–1,160 51
1,161–1,180 35
1,181–1,200 39
1,201–1,220 26
1,221–1,240 37
1,241–1,260 36
1,261–1,280 27
1,281–1,300 32
1,301–1,320 28
1,321–1,340 17
1,341–1,360 30
1,361–1,380 28
1,381–1,400 17
1,401–1,420 21
1,421–1,440 15
1,441–1,460 12
1,461–1,480 12
1,481–1,500 18
1,501–1,520 14
1,521–1,540 17
1,541–1,560 15
1,561–1,580 6
1,581–1,600 2
1,601–1,620 12
1,621–1,640 11
1,641–1,660 8
1,661–1,680 5
1,681–1,700 5
1,701–1,720 10
1,721–1,740 12
1,741–1,760 14
1,761–1,780 6
1,781–1,795 5
1,796+ 100
Download as CSV

Ann H. Partridge D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Ann H. Partridge sits on this spectrum.

No. of scientists
250 500 750 1,000
Bar chart with 75 bars. Horizontal axis: D-Index, 70–71 to 217+. Vertical axis: number of scientists, 0 to 1,027. Most scientists, 1,027, have 82–83 D-Index. The last bar groups every scientist with 217 D-Index or more. The highlighted bar, 100–101 D-Index, is where this scientist sits. 70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70–71 D-Index 217+

This scientist: 100 D-Index — 60th percentile

60% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

View D-Index distribution as a table
Number of Medicine scientists by D-index, Research.com 2026 ranking edition. Based on 20,134 ranked scientists.
D-Index Scientists This scientist
70–71 226
72–73 391
74–75 574
76–77 730
78–79 891
80–81 972
82–83 1,027
84–85 1,003
86–87 960
88–89 970
90–91 922
92–93 839
94–95 808
96–97 779
98–99 668
100–101 611 100
102–103 630
104–105 513
106–107 541
108–109 445
110–111 429
112–113 399
114–115 393
116–117 318
118–119 302
120–121 287
122–123 255
124–125 256
126–127 252
128–129 230
130–131 179
132–133 168
134–135 163
136–137 159
138–139 134
140–141 134
142–143 118
144–145 109
146–147 106
148–149 74
150–151 79
152–153 80
154–155 87
156–157 57
158–159 74
160–161 69
162–163 60
164–165 53
166–167 39
168–169 42
170–171 32
172–173 39
174–175 40
176–177 28
178–179 19
180–181 23
182–183 31
184–185 18
186–187 20
188–189 22
190–191 13
192–193 21
194–195 12
196–197 12
198–199 14
200–201 15
202–203 13
204–205 10
206–207 8
208–209 4
210–211 12
212–213 11
214–215 10
216 4
217+ 98
Download as CSV

Overview

Ann H. Partridge is affiliated with Harvard University in the United States and has a research focus primarily in Medicine and Biochemistry, Genetics and Molecular Biology. Their specialization encompasses Oncology, Cancer Research, Pulmonary and Respiratory Medicine, Genetics, and Public Health, Environmental and Occupational Health.

Their work extensively covers topics related to breast cancer treatment studies, cancer risks and factors, cancer survivorship and care, advanced breast cancer therapies, reproductive biology and fertility, BRCA gene mutations in cancer, and HER2/EGFR in cancer research.

Key recent publications by Ann H. Partridge include the following:

  • Customizing local and systemic therapies for women with early breast cancer: the St. Gallen International Consensus Guidelines for treatment of early breast cancer 2021, published in 2021 in Annals of Oncology
  • Early breast cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up, published in 2023 in Annals of Oncology
  • Evidence-based approaches for the management of side-effects of adjuvant endocrine therapy in patients with breast cancer, published in 2021 in The Lancet Oncology
  • ESO-ESMO 4th International Consensus Guidelines for Breast Cancer in Young Women (BCY4), published in 2020 in Annals of Oncology
  • Interrupting Endocrine Therapy to Attempt Pregnancy after Breast Cancer, published in 2023 in New England Journal of Medicine

The frequent co-authors associated with Partridge's work include Kathryn J. Ruddy, Shoshana M. Rosenberg, Eric P. Winer, Virginia F. Borges, and Lisa A. Carey.

Their research has been published in a variety of journals, with prominent venues including:

  • Journal of Clinical Oncology
  • Cancer Research
  • Clinical Cancer Research
  • UNC Libraries
  • The Breast

Ann H. Partridge's scholarly contributions span across multiple subfields with a strong emphasis on clinical and translational oncology. Their research often addresses both therapeutic strategies and survivorship issues in breast cancer, combining clinical practice guidelines and molecular approaches. This positions them as an active contributor to understanding and managing breast cancer treatment and its wider implications for patient care and fertility considerations.

Best Publications

  • Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013

    A Goldhirsch;E P Winer;A S Coates;R D Gelber

  • American Society of Clinical Oncology Recommendations on Fertility Preservation in Cancer Patients

    Stephanie J. Lee;Leslie R. Schover;Ann H. Partridge;Pasquale Patrizio

  • Fertility Preservation for Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update

    Alison W. Loren;Pamela B. Mangu;Lindsay Nohr Beck;Lawrence Brennan

  • Fertility Preservation in Patients With Cancer: ASCO Clinical Practice Guideline Update.

    Kutluk Oktay;Brittany E. Harvey;Ann H. Partridge;Gwendolyn P. Quinn

  • De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017

    G. Curigliano;H. J. Burstein;E. P. Winer;M. Gnant

  • Web-based survey of fertility issues in Young women with breast cancer

    Ann H. Partridge;Shari Gelber;Jeffrey Peppercorn;Ebonie Sampson

  • Screening, Assessment, and Care of Anxiety and Depressive Symptoms in Adults With Cancer: An American Society of Clinical Oncology Guideline Adaptation

    Barbara L. Andersen;Robert J. DeRubeis;Barry S. Berman;Jessie Gruman

  • Adjuvant paclitaxel and trastuzumab for node-negative, HER2-positive breast cancer.

    Sara M. Tolaney;William T. Barry;Chau T. Dang;Denise A. Yardley

  • Adherence to Therapy With Oral Antineoplastic Agents

    Ann H. Partridge;Jerry Avorn;Philip S. Wang;Eric P. Winer

  • Nonadherence to Adjuvant Tamoxifen Therapy in Women With Primary Breast Cancer

    Ann H. Partridge;Philip S. Wang;Eric P. Winer;Jerry Avorn

  • Patient adherence and persistence with oral anticancer treatment

    Kathryn Ruddy;Erica Mayer;Ann Partridge

  • Cancer and fertility preservation: international recommendations from an expert meeting

    Matteo Lambertini;Lucia Del Mastro;Maria M.C. Pescio;Claus Yding Andersen

  • Adherence to Initial Adjuvant Anastrozole Therapy Among Women With Early-Stage Breast Cancer

    Ann H. Partridge;Andrea LaFountain;Erica Mayer;Brooke S. Taylor

  • Goserelin for ovarian protection during breast-cancer adjuvant chemotherapy.

    Halle C F Moore;Joseph M. Unger;Kelly Anne Phillips;Frances Boyle;Frances Boyle

  • Adjuvant Chemotherapy in Older Women with Early-Stage Breast Cancer

    Hyman B. Muss;Hyman B. Muss;Donald A. Berry;Constance T. Cirrincione;Maria Theodoulou

  • Clinical Activity of Trastuzumab and Vinorelbine in Women With HER2-Overexpressing Metastatic Breast Cancer

    Harold J. Burstein;Irene Kuter;Susana M. Campos;Rebecca S. Gelman

  • Side effects of chemotherapy and combined chemohormonal therapy in women with early-stage breast cancer.

    Ann H. Partridge;Harold J. Burstein;Eric P. Winer

  • Biology of breast cancer in young women

    Hatem Hamdy Abdel Azim;Ann A.H. Partridge

  • Correction to: De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017 (Annals of Oncology (2017) 28(8) (1700–1712), (S0923753419321817), (10.1093/annonc/mdx308))

    G. Curigliano;H. J. Burstein;E. P. Winer;M. Gnant

  • Goserelin for Ovarian Protection During Breast-Cancer Adjuvant Chemotherapy

    Halle C.F. Moore;Joseph M. Unger;Kelly Anne Phillips;Frances Boyle;Frances Boyle

Frequent Co-Authors

Eric P. Winer
Eric P. Winer Yale University
Rulla M. Tamimi
Rulla M. Tamimi Cornell University
Virginia F. Borges
Virginia F. Borges University of Colorado Boulder
Harold J. Burstein
Harold J. Burstein Harvard University
Lisa A. Carey
Lisa A. Carey University of North Carolina at Chapel Hill
Sara M. Tolaney
Sara M. Tolaney Harvard University
Antonio C. Wolff
Antonio C. Wolff Johns Hopkins University
Ian E. Krop
Ian E. Krop Harvard University
Clifford A. Hudis
Clifford A. Hudis Memorial Sloan Kettering Cancer Center
Karen M. Emmons
Karen M. Emmons Harvard University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in medicine isn’t limited to traditional medical school routes. Many students consider direct entry nursing programs as an alternative and faster pathway into healthcare. These programs are designed for those with prior bachelor’s degrees or relevant experience, offering flexibility and shorter completion times.

For those more interested in administrative or technology roles, earning a degree in health information management is a strong option. There are several reputable medical billing and coding financial aid programs available online, making this career much more accessible and affordable.

If standardized testing is a concern, consider applying to a nursing school that does not require teas test. This allows you to focus on essential coursework and clinical experience without the pressure of entrance exams.

Leadership roles in healthcare are also in demand. Students interested in overseeing healthcare systems can pursue a health care administration degree online, which provides a flexible learning schedule and accelerated degree paths.

With so many diverse paths and online opportunities, pursuing a healthcare career in the US is more accessible than ever.

Best Scientists Citing Ann H. Partridge

Trending Scientists

Recently Published Articles